Jeenah Moon/Getty Images News
- Pfizer’s (NYSE:PFE) breast cancer drug Ibrance, also known as palbociclib, showed encouraging results in the treatment of a certain type of appendix cancer, according to a new study.
- The study showed that palbociclib was able to stabilize tumor growth and
